Professional Summary

Professional Overview

Vincent Van Der Wel is a versatile and accomplished professional with extensive experience in the pharmaceutical and healthcare industries. As the Founder of Orfenix, he spearheads innovative strategies and drives business development initiatives. Concurrently, he serves as an Executive Director at Haltex Therapeutics, a Board Member at EYES - Emerging Young Entrepreneurs Society, and in various advisory and support roles across other healthcare and technology organizations.

Experience Summary

Current Roles

Founder, Orfenix (2021-01-01 to Present)

Established Orfenix, a pioneering pharmaceutical company, and currently oversees all strategic and operational aspects

Leads the development of novel drug therapies and collaborates with industry partners to advance research and commercialization

Board Member, EYES - Emerging Young Entrepreneurs Society (2024-02-01 to Present)

Provides strategic guidance and mentorship to early-stage entrepreneurs in the healthcare and technology sectors

Leverages extensive industry knowledge to support the growth and success of emerging businesses

Executive Director, Haltex Therapeutics (2023-01-01 to Present)

Responsible for the overall management and direction of Haltex Therapeutics, a leading pharmaceutical research and development firm

Spearheads the development and implementation of strategic initiatives to drive innovation and market expansion

Previous Experience

Strategy and Finance, MyMicroZoo (2020-01-01 to Present)

Supports the strategic and financial planning for this innovative biotechnology company

Collaborates with the leadership team to identify growth opportunities and optimize business operations

Business Development Support, Amsterdam UMC (2019-01-01 to Present)

Assists in the development and management of pharmaceutical partnerships and collaborations

Leverages industry expertise to facilitate successful partnerships and drive research and development initiatives

Executive Director, Patient One (2016-01-01 to Present)

Oversees the day-to-day operations and strategic direction of this patient-focused healthcare organization

Ensures the delivery of high-quality services and the implementation of innovative patient-centric programs

Academic Background

Vincent Van Der Wel holds a Master's degree in Pharmaceutical Sciences from the University of Leiden, where he graduated with distinction.

Areas of Expertise

Pharmaceutical and healthcare industry expertise

Strategic planning and business development

Innovative drug therapy development

Pharmaceutical partnerships and collaborations

Entrepreneurship and emerging business support

Financial and operational management

Professional Impact

Spearheaded the establishment of Orfenix, a leading pharmaceutical company, and currently oversees its strategic direction and growth

Serves as a trusted advisor and board member for various healthcare and technology organizations, contributing to their success and expansion

Leverages extensive industry knowledge and expertise to support the development and commercialization of novel drug therapies and facilitate successful pharmaceutical partnerships

Conclusion

With his diverse background, strategic acumen, and unwavering commitment to innovation, Vincent Van Der Wel is poised to continue making a significant impact in the pharmaceutical and healthcare industries. His multifaceted expertise and proven track record of driving successful initiatives position him as a valuable asset to the organizations he serves.